The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 12, 2021

Filed:

Dec. 16, 2016
Applicant:

Lonza Consumer Health Inc., Morristown, NJ (US);

Inventors:

Aouatef Bellamine, Pennington, NJ (US);

Ilya Zhivkovich, Milford, PA (US);

Ulla Freitas, Lorrach, DE;

Assignee:

Lonza Consumer Health Inc., Morristown, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23K 20/174 (2016.01); A23K 20/142 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A23L 33/17 (2016.01); A23L 2/66 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 33/00 (2006.01); A61K 31/198 (2006.01); A61K 31/593 (2006.01); A61K 31/197 (2006.01); A61K 31/205 (2006.01); A61K 45/06 (2006.01); A61P 21/00 (2006.01); A23K 20/20 (2016.01); A23C 9/152 (2006.01);
U.S. Cl.
CPC ...
A61K 31/593 (2013.01); A23K 20/142 (2016.05); A23K 20/174 (2016.05); A23K 20/30 (2016.05); A23L 2/66 (2013.01); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/17 (2016.08); A61K 9/16 (2013.01); A61K 9/20 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/205 (2013.01); A61K 33/00 (2013.01); A61K 45/06 (2013.01); A23C 9/1526 (2013.01); A23V 2002/00 (2013.01);
Abstract

A method and composition for preserving muscle mass and function by increasing muscle protein synthesis and/or decreasing muscle protein degradation in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at least two of an essential amino acid, an amino acid derivative, and a nitrogenous organic acid. In a particular embodiment, the protein building composition comprises leucine, L-carnitine, and creatine. The protein building composition can decrease TNF-α and increase mTOR expression in muscle.


Find Patent Forward Citations

Loading…